Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Evan M Braunstein, MDPhD, Donna Marie Williams, PhD, Igor Makhlin, MD, Aparna Pallavajjala, Christopher D Gocke, MD, Nara Sobreira, MD, Kala Visvanathan, MD, Linda Resar, MD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2017) 130 (Supplement 1): 1663.

https://doi.org/10.1182/blood.V130.Suppl_1.1663.1663

Published: 2017

Journal Articles

Novel Technologies to Detect Minimal Residual Disease

Todd E. Druley, MD PhD

Blood (2016) 128 (22): SCI-31.

https://doi.org/10.1182/blood.V128.22.SCI-31.SCI-31

Published: 2016

Journal Articles

Kidney Damage in the Manifestation of Lymphoproliferative Diseases

Dzhumabaeva Tolgonbaevna Boldukyz, PhD MD, Birjukova Semenovna Ludmila, PhD MD, Julhakyan Hunan, PhD MD, Maryna Saliya, N, Roshchina Sergeevna Ludmila, PhD

Blood (2016) 128 (22): 5313.

https://doi.org/10.1182/blood.V128.22.5313.5313

Published: 2016

Journal Articles

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Benedetta Mazzi, BSc, Roberto Crocchiolo, MD, Didier Blaise, MD, Lisbeth Barkholt, MD, Jacques-Olivier Bay, MD, PhD, Rocco Pastano, MD, Margherita Torchio, PhD, Stefania Trinca, DM, Jacopo Peccatori, MD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Marco Bregni, MD

Blood (2012) 120 (21): 4667.

https://doi.org/10.1182/blood.V120.21.4667.4667

Published: 2012

Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Alain Delmer, MD, Olivier Tournilhac, MD, PhD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Brigitte Dreyfus, MD, Beatrice Mahe, Michel Leporrier, MD, Anne-Sophie Michallet, MD, Arnaud Jaccard, Marine Divine, MD, Vincent Levy, MD, Florence Cymbalista, Pr, Remi Letestu, MD

Blood (2011) 118 (21): 3900.

https://doi.org/10.1182/blood.V118.21.3900.3900

Published: 2011

Journal Articles

Cell Cycle Regulation by Iron: Novel Approaches to Mantle Cell Lymphoma Therapy.

Heather Gilbert, MD, John Cumming, Josef T. Prchal, MD

Blood (2009) 114 (22): 2515.

https://doi.org/10.1182/blood.V114.22.2515.2515

Published: 2009

Journal Articles

Depletion of Vascular Endothelial Progenitor Cells Inhibits Inflammation

Olaf Penack, Erik Henke, David Suh, Christopher King, Marsinay O Smith, Il-Kang Na, MD, Amanda Holland, Arnab Ghosh, Sydney X Lu, Robert Jenq, Chen Liu, George F Murphy, Theresa Lu, Chad May, David A. Scheinberg, MD, PhD, Ding Cheng Gao, Vivek Mittal, Robert Benezra, Marcel Van Den Brink, MD, PhD

Blood (2008) 112 (11): 694.

https://doi.org/10.1182/blood.V112.11.694.694

Published: 2008

Journal Articles

Acute Kidney Injury in Patients Receiving Subcutaneous Deferoxamine Therapy.

Arjuna Ponnampalam, MD, Donald S Houston, MD, PhD

Blood (2008) 112 (11): 3851.

https://doi.org/10.1182/blood.V112.11.3851.3851

Published: 2008

Journal Articles

Selective Depletion of Alloreactive T Cells and Study of Anti-Tumor Activity of Specific T Cell Clones in Patients with Leukemia and Renal Carcinoma.

Eva Matejkova, MSc, Ivana Buresova, RNDr., Petra Vidlakova, Drahomira Kyjovska, Ellen S. Vitetta, MD, Jaroslav Michalek, MUDr.PhD.

Blood (2007) 110 (11): 3250.

https://doi.org/10.1182/blood.V110.11.3250.3250

Published: 2007

Journal Articles

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Jacalyn Rosenblatt, MD, Zekui Wu, MD, Corrine Lenahan, MD, Adam Bissonnette, Baldev Vasir, PhD, Kenneth Miller, MD, Robin Joyce, MD, James Levine, MD, Ilene Galinsky, RN, Richard Stone, MD, Donald Kufe, MD, David Avigan, MD

Blood (2007) 110 (11): 1794.

https://doi.org/10.1182/blood.V110.11.1794.1794

Published: 2007

Journal Articles

Other Tumours in Primary Cutaneous Lymphomas.

Serena Rupoli, MD, G. Goteri, MD, P. Picardi, MD, S. Pulini, MD, A. Tassetti, MD, S. Mulattieri, MD, A. Stronati, MD, A.R. Scortechini, MD, G. Brandozzi, MD, G. Filosa, MD, M. Simonacci, MD, G. Ricotti, MD, M. Ottaviani, MD, A. Campanati, MD, E. Grilli Cicilioni, MD, M. Giangiacomi, MD, Pietro Leoni, MD

Blood (2007) 110 (11): 4417.

https://doi.org/10.1182/blood.V110.11.4417.4417

Published: 2007

Journal Articles

Stimulation of Anti-Tumor Immunity Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28.

Jacalyn Rosenblatt, MD, Zekui Wu, MD, Corrine Lenahan, MD, Baldev Vasir, PhD, Adam Bissonnette, Donald Kufe, MD, David Avigan, MD

Blood (2006) 108 (11): 3715.

https://doi.org/10.1182/blood.V108.11.3715.3715

Published: 2006

Journal Articles

Immunotherapy with Cytokine Induced Killer Cells in Solid and Hematopoietic Tumors: Preliminary Data.

Paola Olioso, MD, Raffaella Giancola, MD, Maria Di Riti, Patrizia Accorsi, MD, Antonio Spadano, MD, Dino Natale, MD, Roberto Rossetti, MD, Paolo Di Bartolomeo, MD, Antonio Iacone

Blood (2005) 106 (11): 2395.

https://doi.org/10.1182/blood.V106.11.2395.2395

Published: 2005

NARROW

Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms

Novel Technologies to Detect Minimal Residual Disease

Kidney Damage in the Manifestation of Lymphoproliferative Diseases

Improved Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Metastatic Renal Cancer Associated with Homozygosity for the HLA-G 14 Base-Pair Deletion Polymorphism: An EBMT STWP Study

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Cell Cycle Regulation by Iron: Novel Approaches to Mantle Cell Lymphoma Therapy.

Depletion of Vascular Endothelial Progenitor Cells Inhibits Inflammation

Acute Kidney Injury in Patients Receiving Subcutaneous Deferoxamine Therapy.

Selective Depletion of Alloreactive T Cells and Study of Anti-Tumor Activity of Specific T Cell Clones in Patients with Leukemia and Renal Carcinoma.

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Other Tumours in Primary Cutaneous Lymphomas.

Stimulation of Anti-Tumor Immunity Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28.

Immunotherapy with Cytokine Induced Killer Cells in Solid and Hematopoietic Tumors: Preliminary Data.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only